Groups | VDG a (n = 1) | VDG b (n = 28) | VDG c (n = 107) | VDG d (n = 49) | Total | P value |
---|---|---|---|---|---|---|
Infiltrating ductal carcinoma | 1 | 25 | 104 | 45 | 175 | 0.312 |
Invasive lobular carcinoma | 0 | 0 | 1 | 0 | 1 | |
Malignant phyllodes | 0 | 0 | 0 | 2 | 2 | |
Mucinous carcinoma | 0 | 0 | 0 | 1 | 1 | |
Primary lymphoma of breast | 0 | 1 | 0 | 0 | 1 | |
DCIS | 0 | 0 | 1 | 0 | 1 | |
Paget's disease | 0 | 0 | 0 | 1 | 1 | |
Neuroendocrine tumor | 0 | 1 | 0 | 0 | 1 | |
Invasive papillary carcinoma | 0 | 0 | 1 | 0 | 1 | |
Carcino-sarcoma | 0 | 1 | 0 | 0 | 1 | |
Ki 67# | ||||||
≤ 14 | 1 | 0 | 1 | 1 | 3 | |
> 14 | 0 | 1 | 5 | 5 | 11 | |
ER* | 1 | 7 | 29 | 18 | 55 | 0.263 |
PR* | 1 | 7 | 25 | 21 | 54 | 0.197 |
Her 2-neu* | 0 | 4 | 26 | 8 | 38 | 0.75 |
Hormone receptor groups | ||||||
Triple-negative | 0 | 5 | 22 | 10 | 37 | < 0.001 |
Her2 positive | 0 | 3 | 23 | 5 | 31 | 0.237 |
Luminal | 1 | 8 | 30 | 20 | 59 | 0.867 |